FBLG
FibroBiologics, Inc.
+0.10 (+6.99%)1.53USD74.2K成交股數10.2M市值0.6本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.7M | 3.0M | 797K | 2.8M | 2.0M | 1.8M | 1.2M | 975K | 960K | 772K | 571K | 547K |
| 銷售管理費用 | 2.4M | 2.1M | 1.8M | 2.2M | 2.4M | 2.8M | 2.1M | 2.2M | 2.5M | 1.7M | 1.5M | 1.5M |
| 營業利益 | −4.0M-10% | −5.1M+12% | −2.6M-23% | −5.0M+56% | −4.5M+30% | −4.5M+83% | −3.4M+63% | −3.2M+54% | −3.5M | −2.5M | −2.1M | −2.1M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −4.1M-12% | −5.0M+1% | −3.2M+549% | −5.8M-743% | −4.7M-45% | −5.0M-49% | −500K-77% | 898K-142% | −8.5M | −9.7M | −2.2M | −2.2M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.66-73% | -1.33-51% | 4.83-48400% | -0.13-533% | -2.41+793% | -2.71+697% | -0.01-88% | 0.03-138% | -0.27 | -0.34 | -0.08 | -0.08 |
| 稀釋股數 | 6.3M | 3.8M | 44.7M | 43.1M | 1.9M | 1.8M | 33.5M | 32.7M | 31.1M | 28.2M | 28.2M | 28.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.5M | 1.5M | 4.9M | 4.9M | 8.8M | 8.7M | 7.8M | 6.0M | 8.2M | 9.2M | 10.8M | 11.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 7.9M | 5.9M | 9.6M | 8.7M | 13.9M | 11.4M | 10.5M | 8.9M | 11.4M | 11.8M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 3.3M | 3.3M | 3.5M | 8.6M | 13.0M | 9.1M | 7.7M | 11.3M | 15.3M | 10.6M | – | – |
| 股東權益 | 4.6M | 2.6M | 6.2M | 125K | 860K | 2.4M | 2.7M | −2.4M | −3.9M | 1.3M | 10.5M | 11.4M |
| 負債比 | 41.5% | 56.2% | 36.0% | 98.6% | 93.8% | 79.4% | 73.9% | 126.8% | 133.9% | 89.4% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.4M-17% | – | – | – | −5.3M | – | – | −4.3M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 43K | – | – | 8K | – | – | – |
| 自由現金流 | – | −4.4M-18% | – | – | – | −5.3M | – | – | −4.3M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −18.6M | –% | -0.42 | −16.7M |
| FY2024 | – | – | −11.2M | –% | -0.34 | −12.1M |
| FY2023 | – | – | −16.5M | –% | -0.68 | −6.9M |
| FY2022 | – | – | −5.1M | –% | -0.18 | – |